GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:12746280

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Kageyama, K and Suda, T (2003) Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. Endocrinology 144:2234-41

Abstract

Corticotropin-releasing factor receptor type 2beta, expressed in the rodent cardiovascular system, is a member of the G protein-coupled receptor family. This receptor is coupled positively to adenylate cyclase and is bound preferentially by the urocortin (Ucn)-related peptides (Uncs): Ucn, Ucn II, and Ucn III. In the present study, we investigated the effects of Ucns on IL-6 levels in A7r5 aortic smooth muscle cells. In this cell line, both Ucn and Ucn II induced accumulation of intracellular cAMP via corticotropin-releasing factor receptor type 2beta and also caused a significant increase in IL-6 output levels. The adenylate cyclase inhibitor, MDL-12330A, inhibited this Ucn- or Ucn II-induced increase in IL-6 levels. Although H89 (10 micro M), a protein kinase A inhibitor, had no effect on the increase in IL-6 concentration, bisindolylmaleimide I (10 nM), a protein kinase C inhibitor, was found to significantly inhibit IL-6 output levels. Blockade of Ucn- or Ucn II-induced increases in IL-6 levels by SB203580 (100 nM), a p38 MAPK inhibitor, suggested that the p38 MAPK pathway was involved in this regulation. The cAMP-mediated increase in IL-6 levels was suppressed synergistically by both bisindolylmaleimide I and SB203580. These findings demonstrate that both protein kinase C and p38 MAPK signaling cascades are involved downstream of the Ucns-cAMP pathway in A7r5 aortic smooth muscle cells.

Links

PubMed

Keywords

Animals; Aorta/cytology; Cells, Cultured; Corticotropin-Releasing Hormone/pharmacology; Cyclic AMP/metabolism; Cyclic AMP-Dependent Protein Kinases/metabolism; Enzyme Inhibitors/pharmacology; Flavonoids/pharmacology; Imidazoles/pharmacology; Imines/pharmacology; Indoles/pharmacology; Interleukin-6/metabolism; Isoquinolines/pharmacology; MAP Kinase Signaling System/drug effects; MAP Kinase Signaling System/physiology; Maleimides/pharmacology; Mitogen-Activated Protein Kinases/metabolism; Muscle, Smooth, Vascular/cytology; Muscle, Smooth, Vascular/drug effects; Muscle, Smooth, Vascular/metabolism; Protein Kinase C/metabolism; Pyridines/pharmacology; Rats; Sulfonamides; Urocortins

public



Cancel